Suchergebnisse
10
Alles
Interim analysis of 1-level BAGUERA®C IDE study meets threshold for non-inferiority
11. März 2025 07:00 ET
|
Spineart
Interim analysis of 1-level BAGUERA®C IDE study meets threshold for non-inferiority Geneva, March 11, 2025 – Spineart, a fast-growing company in spine surgery innovation, today announces that it has...